## Research-question validation

### Phenomenon-vs-method check

**Verdict**: pass

The question asks about the relationship between specific vaccine types and the rates of reported adverse event categories, independent of the specific statistical algorithms used. While the methodology mentions ROR, PRR, and IC, the core inquiry is whether certain adverse events are disproportionately associated with COVID-19 vaccination compared to other vaccines or background rates, which is a substantive epidemiological question.

### Circularity check

**Verdict**: pass

The predictor variables (vaccine type and time since vaccination) are distinct from the outcome variables (adverse event categories coded in MedDRA). The background rates and non-COVID vaccine baselines are derived from independent datasets or established epidemiological data, ensuring the comparison is not mechanically guaranteed by the data construction itself.

### Triviality check

**Verdict**: pass

A positive result identifying specific elevated signals would be actionable for public health surveillance, while a null result (finding no disproportionate reporting after rigorous adjustment) would be scientifically valuable to counter misinformation or confirm safety profiles. Given the high volume of public debate and the known biases of spontaneous reporting systems, rigorously quantifying these signals is not predetermined by simple domain knowledge.

### Question-narrowing check

**Verdict**: pass

The question names a domain relationship (association between vaccine type and adverse event frequency) rather than focusing on implementation constraints like CPU speed or memory usage. The mention of a 7GB RAM constraint in the methodology sketch does not contaminate the research question itself, which remains focused on the statistical evidence of safety signals.

### Overall verdict

**Verdict**: validated

The research question is well-posed, focusing on a genuine scientific inquiry into vaccine safety signals using appropriate comparative baselines. It avoids implementation-method narrowing and circularity, and the potential outcomes (both positive and null) hold significant value for the field of pharmacovigilance. The project is ready to advance to initialization.
